FAT1 and neoplasm: For example, disrupting the binding of KK-LC-1 to FAT1 can lead to a reduction in ALDH1A1 transcription, which reduces ALDH + cell stemness and viability and ultimately leads to the inhibition of TNCB tumour growth [58].